{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:24:53Z","timestamp":1790112293908,"version":"4.0.1"},"reference-count":300,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejogrb.2023.11.013","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T19:00:19Z","timestamp":1700074819000},"page":"210-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-520X","authenticated-orcid":false,"given":"Jo","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Edey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Faruqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hillaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.11.013_b0005","unstructured":"Gore M, Bagwan I, Board R, Capper S, Coupland S, Lalondrelle S, et al. Ano-uro-genital Mucosal Melanoma. Full Guideline: Melanoma Focus; 2018 [Available from: https:\/\/melanomafocus.com\/wp-content\/uploads\/2018\/05\/2_Full-Guideline-V.7.4-FINAL-29.5.18.pdf."},{"key":"10.1016\/j.ejogrb.2023.11.013_b0010","unstructured":"Cancer Research UK. Vulval Cancer Incidence [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vulval-cancer\/incidence."},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/1471-0528.12459","article-title":"Vulval cancer incidence, mortality and survival in England: age-related trends","volume":"121","author":"Lai","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0020","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-16-0019","article-title":"Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma","author":"Bleeker","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0025","unstructured":"Cancer Research UK. Vulval Cancer Mortality Data [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/vulval-cancer\/mortality."},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0030","doi-asserted-by":"crossref","first-page":"e0128073","DOI":"10.1371\/journal.pone.0128073","article-title":"Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999\u20132011. A population-based cancer registry analysis","volume":"10","author":"Buttmann-Schweiger","year":"2015","journal-title":"PLoS One"},{"issue":"21\u201322","key":"10.1016\/j.ejogrb.2023.11.013_b0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00508-017-1255-2","article-title":"HPV prevalence in vulvar cancer in Austria","volume":"129","author":"Pils","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0040","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, L M, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today Lyon, Frabce: International Agency for Research on Cancer; 2020 [Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/21-Vulva-fact-sheet.pdf."},{"key":"10.1016\/j.ejogrb.2023.11.013_b0045","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in males and females","volume":"11","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0055","article-title":"Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination","volume":"5","author":"Henschke","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.amepre.2021.06.026","article-title":"High-grade vulvar, vaginal, and anal precancers among U.S. Adolescents and Young Adults after human papillomavirus vaccine introduction","volume":"62","author":"Mix","year":"2022","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107302","article-title":"Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001\u20132017","volume":"164","author":"Mix","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0070","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0075","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2+","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0085","article-title":"HPV vaccination after primary treatment of HPV-related disease across different organ sites: A multidisciplinary comprehensive review and meta-analysis","volume":"10","author":"Di Donato","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0090","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2005.02.012","article-title":"Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients","volume":"97","author":"van Seters","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0100","first-page":"CD011837","article-title":"Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia","volume":"1","author":"Lawrie","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2010.12.340","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial","volume":"121","author":"Terlou","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0110","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/ced.13874","article-title":"Impact of smoking on imiquimod response in patients with vulval intraepithelial neoplasia","volume":"44","author":"Harvey","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.11.013_b0115","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S1470-2045(14)70456-5","article-title":"Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT(3)VIN): a multicentre, open-label, randomised, phase 2 trial","volume":"15","author":"Tristram","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/1471-0528.15124","article-title":"Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)","volume":"125","author":"Hurt","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0125","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/AOG.0000000000001713","article-title":"Management of vulvar intraepithelial neoplasia","volume":"128","author":"Gynecologists CONACoOa","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"10337","key":"10.1016\/j.ejogrb.2023.11.013_b0130","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(22)00469-X","article-title":"Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial","volume":"399","author":"Trutnovsky","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12905-018-0707-9","article-title":"HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review","volume":"19","author":"Bryan","year":"2019","journal-title":"BMC Womens Health"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.140.6.702","article-title":"Does treatment of vulvar lichen sclerosus influence its prognosis?","volume":"140","author":"Cooper","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0145","doi-asserted-by":"crossref","DOI":"10.1097\/LGT.0000000000000673","article-title":"Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review","author":"Vieira-Baptista","year":"2022","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ajd.12873","article-title":"Incidence of vulval squamous cell carcinoma in women with vulval lichen sclerosus in an Australian tertiary referral centre","volume":"60","author":"Meani","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archderm.140.6.709","article-title":"Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease","volume":"140","author":"Renaud-Vilmer","year":"2004","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CJI.0000000000000148","article-title":"Sequencing treatment in BRAFV600 mutant melanoma: Anti-PD-1 before and After BRAF inhibition","volume":"40","author":"Johnson","year":"2017","journal-title":"J Immunother"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","article-title":"Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age","volume":"45","author":"van de Nieuwenhof","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/LGT.0b013e31818b8c13","article-title":"Vulvar cancer and the need for awareness of precursor lesions","volume":"13","author":"Maclean","year":"2009","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jogc.2021.09.023","article-title":"Risk of vulvar squamous cell carcinoma in lichen sclerosus and lichen planus: a systematic review","volume":"44","author":"Leis","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0000000000000375","article-title":"HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is associated with an aggressive clinical course","volume":"36","author":"McAlpine","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0190","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PGP.0000000000000280","article-title":"The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges","volume":"35","author":"Bigby","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0195","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.16241","article-title":"British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018","volume":"178","author":"Lewis","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijgo.12818","article-title":"Relationship between vulvar symptoms and incidence of vulvar cancer in women referred to a rapid access clinic","volume":"145","author":"Wiggans","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0205","unstructured":"NICE. Suspected cancer: recognition and referral. NICE guideline [NG12] National Collaborating Centre for Cancer; 2015 Published date: June 2015 Last updated: July 2017."},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2012.07.118","article-title":"Vulvar intraepithelial neoplasia (VIN 2\/3): comparing clinical outcomes and evaluating risk factors for recurrence","volume":"127","author":"Wallbillich","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Suppl 6","key":"10.1016\/j.ejogrb.2023.11.013_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hiv.13015","article-title":"British HIV Association\/British Association for Sexual Health and HIV\/British Infection Association adult HIV testing guidelines 2020","volume":"21","author":"Palfreeman","year":"2020","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4251\/wjgo.v9.i2.50","article-title":"Anal intraepithelial neoplasia: A review of diagnosis and management","volume":"9","author":"Roberts","year":"2017","journal-title":"World J Gastrointest Oncol"},{"issue":"3 Suppl 1","key":"10.1016\/j.ejogrb.2023.11.013_b0225","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/LGT.0000000000000117","article-title":"Screening for anal cancer in women","volume":"19","author":"Moscicki","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"13","key":"10.1016\/j.ejogrb.2023.11.013_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133082","article-title":"The role of ultrasound in the evaluation of inguinal lymph nodes in patients with vulvar cancer: a systematic review and meta-analysis","volume":"14","author":"Verri","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2009.12.017","article-title":"The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study","volume":"117","author":"Kataoka","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1590\/0100-3984.2018.0072","article-title":"State of the art in vulvar cancer imaging","volume":"52","author":"Serrado","year":"2019","journal-title":"Radiol Bras"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0245","unstructured":"WHO Classification of Tumours Editorial Board. Female Genital Tumours. 2020. In: WHO Classification of Tumours, 5th edn, Vol 4 [Internet]. IARC; [419-49]."},{"key":"10.1016\/j.ejogrb.2023.11.013_b0250","doi-asserted-by":"crossref","unstructured":"Bornstein J, Bogliatto F, Haefner H, Stockdale C, Preti M, Bohl T, et al. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions. Consensus vulvar pain terminology committee of the International Society for the Study of vulvovaginal Disease (ISSvD), the International Society for the Study of women\u02bcs Sexual Health (ISSwSH), and the International pelvic pain Society (IppS). Obstet Gynecol. 2016;127(2):264-8.","DOI":"10.1097\/AOG.0000000000001285"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0255","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00000478-200405000-00012","article-title":"Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma?","volume":"28","author":"Nascimento","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b0260","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41379-022-01079-7","article-title":"HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva","volume":"35","author":"Parra-Herran","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/LGT.0000000000000572","article-title":"Diagnostic criteria for differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation","volume":"25","author":"Heller","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b0270","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PAS.0b013e3181b40081","article-title":"HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN","volume":"33","author":"Ordi","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PGP.0000000000000509","article-title":"Classic vulvar intraepithelial neoplasia with superimposed lichen simplex chronicus: a unique variant mimicking differentiated vulvar intraepithelial neoplasia","volume":"38","author":"Watkins","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0280","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-200003000-00013","article-title":"Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PAS.0000000000000291","article-title":"Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss","volume":"39","author":"Singh","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/PGP.0000000000000317","article-title":"Assessment of CK17 as a marker for the diagnosis of differentiated vulvar intraepithelial neoplasia","volume":"36","author":"Podoll","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","article-title":"FIGO staging for carcinoma of the vulva, cervix, and corpus uteri","volume":"125","author":"FIGO Committeeon Gynecologic Oncology","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0300","series-title":"Dataset for histopathological reporting of vulval carcinomas","author":"Faruqi","year":"2018"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijgo.13880","article-title":"FIGO staging for carcinoma of the vulva: 2021 revision","volume":"155","author":"Olawaiye","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.2014.103","article-title":"An alternative way to measure the depth of invasion of vulvar squamous cell carcinoma in relation to prognosis","volume":"28","author":"van den Einden","year":"2015","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0315","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/LGT.0000000000000544","article-title":"Predictive value of an alternative strategy for measuring depth and size of stage 1 vulvar squamous cell carcinoma","volume":"24","author":"Skala","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0320","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European society of gynaecological oncology guidelines for the management of patients with vulvar cancer - update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.11.013_b0325","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/PAS.0000000000000422","article-title":"Perineural invasion is an independent pathologic indicator of recurrence in vulvar squamous cell carcinoma","volume":"39","author":"Holthoff","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0330","first-page":"397","article-title":"Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases","volume":"53","author":"Eva","year":"2008","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0335","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","article-title":"Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma","volume":"142","author":"Yap","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0340","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0345","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","article-title":"The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis","volume":"152","author":"Sand","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0350","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1470-2045(10)70104-2","article-title":"Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study","volume":"11","author":"Oonk","year":"2010","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.ejogrb.2023.11.013_b0355","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0360","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European society of gynaecological oncology guidelines for the management of patients with vulvar cancer","volume":"27","author":"Oonk","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0365","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijgo.12969","article-title":"Corrigendum to \u201cRevised FIGO staging for carcinoma of the cervix uteri\u201d [Int J Gynecol Obstet 145(2019), 129\u2013135]","volume":"147","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0370","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00000478-200203000-00013","article-title":"Recommendations for sentinel lymph node processing in breast cancer","volume":"26","author":"Yared","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0375","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ygyno.2018.10.007","article-title":"Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions","volume":"152","author":"Cibula","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0385","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2016.03.008","article-title":"Paget disease of the vulva","volume":"101","author":"van der Linden","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0390","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2018-000080","article-title":"Reviewing vulvar Paget's disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE","author":"Mantovani","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ogc.2018.09.008","article-title":"Vulvar cancer","volume":"46","author":"Weinberg","year":"2019","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0400","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/IGC.0b013e3182980ffb","article-title":"Vulvar\/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities","volume":"23","author":"Mert","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.11.013_b0405","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0410","first-page":"574","article-title":"Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions","volume":"58","author":"Hacker","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0415","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ejso.2014.03.027","article-title":"Impact of radical operative treatment on the quality of life in women with vulvar cancer\u2013a retrospective study","volume":"40","author":"Gunther","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b0420","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.10969","article-title":"Vulvar carcinoma. The price of less radical surgery","volume":"95","author":"De Hullu","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijgo.13880","article-title":"FIGO staging for carcinoma of the vulva: 2021 revision","volume":"155","author":"Olawaiye","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0430","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-011-1778-0","article-title":"Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva","volume":"18","author":"Woelber","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1758834012471699","article-title":"Management of patients with vulvar cancer: a perspective review according to tumour stage","volume":"5","author":"Woelber","year":"2013","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b0440","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ejso.2018.05.031","article-title":"Surgical margins in squamous cell carcinoma, different for the vulva?","volume":"44","author":"Pleunis","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b0445","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","article-title":"Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group","volume":"45","author":"Raimond","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0450","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of tumour-free margin distance for loco-regional control in vulvar cancer\u2014a subset analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 multicenter study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0455","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/IGC.0000000000001195","article-title":"The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva","volume":"28","author":"Arvas","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0460","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review","volume":"148","author":"Te Grootenhuis","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0465","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/IGC.0b013e3181a12fa2","article-title":"Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma","volume":"19","author":"Eva","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0470","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","article-title":"Margin status revisited in vulvar squamous cell carcinoma","volume":"154","author":"te Grootenhuis","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0475","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3802\/jgo.2016.27.e60","article-title":"Surgical therapy of vulvar cancer: how to choose the correct reconstruction?","volume":"27","author":"Gentileschi","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0480","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/IGC.0b013e318263ef55","article-title":"Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study","volume":"22","author":"Aragona","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0485","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/gyno.1993.1163","article-title":"Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma","volume":"50","author":"Benedetti-Panici","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0490","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","article-title":"Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse","volume":"85","author":"Beriwal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0495","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/IGC.0b013e3181c93adc","article-title":"Neoadjuvant chemotherapy in advanced vulvar cancer","volume":"20","author":"Domingues","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2005.06.068","article-title":"Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration","volume":"100","author":"Geisler","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0505","first-page":"348","article-title":"Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study","volume":"81","author":"Wagenaar","year":"2001","journal-title":"Eur Organiz Res Treatment Cancer Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2017.06.005","article-title":"Bartholin gland cancer","volume":"117","author":"Di Donato","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0515","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/IGC.0000000000000656","article-title":"Carcinoma of the Bartholin gland: a review of 33 cases","volume":"26","author":"Bhalwal","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0520","first-page":"361","article-title":"Primary carcinoma of the Bartholin gland: a report of 14 cases and review of the literature","volume":"60","author":"Leuchter","year":"1982","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0525","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00006250-198606000-00009","article-title":"Bartholin gland carcinoma","volume":"67","author":"Copeland","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0530","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1996.0109","article-title":"Adenoid cystic carcinoma of Bartholin's gland: a review of the literature and report of a patient","volume":"61","author":"DePasquale","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0535","series-title":"World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital","author":"Wilkinson","year":"2003"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0540","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000324","article-title":"Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva","volume":"36","author":"Xing","year":"2017","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0545","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PAS.0000000000000565","article-title":"Lower Female Genital Tract Tumors With Adenoid Cystic Differentiation: P16 Expression and High-risk HPV Detection","volume":"40","author":"Xing","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tjog.2012.10.005","article-title":"Report of two cases of adenoid cystic carcinoma of Bartholin's gland and review of literature","volume":"52","author":"Hsu","year":"2013","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0555","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9378(16)32230-X","article-title":"Adenoid cystic carcinoma of Bartholin's gland. Case report and review of the literature","volume":"147","author":"Bernstein","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0560","doi-asserted-by":"crossref","first-page":"e935707","DOI":"10.12659\/AJCR.935707","article-title":"Adenoid cystic Carcinoma of Bartholin's Gland: a case report with emphasis on surgical management","volume":"23","author":"Verta","year":"2022","journal-title":"Am J Case Rep"},{"issue":"45","key":"10.1016\/j.ejogrb.2023.11.013_b0565","doi-asserted-by":"crossref","first-page":"e31744","DOI":"10.1097\/MD.0000000000031744","article-title":"Adenoid cystic carcinoma of the Bartholin's gland is easily misdiagnosed: A case report and literature review","volume":"101","author":"Wang","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0570","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12905-023-02320-4","article-title":"Adenoid Cystic Carcinoma (ACC) of the Bartholin's gland misdiagnosed for three times: a case report","volume":"23","author":"Alhashemi","year":"2023","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0575","first-page":"115","article-title":"Adenoid cystic carcinoma of Bartholin gland","volume":"67","author":"Copeland","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0580","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2005.08.030","article-title":"Adenoid cystic carcinoma of the Bartholin's gland: report of two cases and review of the literature","volume":"100","author":"Yang","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0585","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(89)90130-3","article-title":"Adenoid cystic carcinoma of Bartholin's gland: a report of five new cases treated with surgery and radiotherapy","volume":"34","author":"Rosenberg","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0590","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0090-8258(91)90014-V","article-title":"Adenoid cystic carcinoma of the vulva: a radiosensitive tumor","volume":"43","author":"Rose","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0595","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ijgc-00009577-200705000-00016","article-title":"Primary treatment of Bartholin's gland carcinoma with radiation and chemoradiation: a report on ten consecutive cases","volume":"17","author":"Lopez-Varela","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0600","first-page":"5688","article-title":"Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands","volume":"8","author":"Yoon","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"10.1016\/j.ejogrb.2023.11.013_b0605","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/1078-0432.CCR-16-2942","article-title":"A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma","volume":"23","author":"Dillon","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0610","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004347-199710000-00005","article-title":"Basal cell carcinoma of the vulva: a clinicopathologic study of 45 cases","volume":"16","author":"Feakins","year":"1997","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejso.2011.12.008","article-title":"Invasive extramammary Paget's disease and the risk for secondary tumours in Europe","volume":"38","author":"van der Zwan","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0620","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gore.2016.12.010","article-title":"Paget's disease of the vulva: a review of 89 cases","volume":"19","author":"Onaiwu","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0625","unstructured":"Royal College of Obstetricians & Gynaecologists. Green-top Guideline No. 58: The Management of Vulval Skin Disorders. London: RCOG; 2011."},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0630","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/bjd.16894","article-title":"Stop routine screening for associated malignancies in cutaneous noninvasive vulvar Paget disease?","volume":"179","author":"van der Linden","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0635","first-page":"CD009245","article-title":"Interventions for the treatment of Paget's disease of the vulva","volume":"6","author":"Edey","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0640","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/IGC.0000000000000901","article-title":"Paget's disease of the vulva: a review of 20 Years' Experience","volume":"27","author":"Parashurama","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0645","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2015.07.097","article-title":"Effects of imiquimod on vulvar Paget's disease: a systematic review of literature","volume":"139","author":"Machida","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.04.012","article-title":"The Paget Trial: Topical 5% imiquimod cream for non-invasive vulvar Paget disease","author":"Van der Linden","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0655","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamadermatol.2018.4793","article-title":"Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary paget disease","volume":"155","author":"Molina","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0660","series-title":"Guidelines for the Diagnosis and Management of Vulval Carcinoma","author":"Royal College of Obstetricians and Gynaecologists","year":"2014"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0665","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0670","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/LGT.0000000000000521","article-title":"Management of malignant vulval melanoma: a retrospective case series and review of the literature","volume":"24","author":"Platt","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0675","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/IGC.0000000000000768","article-title":"Prognostic factors of recurrence and survival in vulvar melanoma: subgroup analysis of the VULvar CANcer Study","volume":"26","author":"Iacoponi","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0680","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2011.11.921","article-title":"Clinicopathologic study of 85 cases of melanoma of the female genitalia","volume":"67","author":"Tcheung","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0685","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.14694\/EdBook_AM.2014.34.e277","article-title":"Management of vulvar and vaginal melanomas: current and future strategies","author":"Leitao","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0690","unstructured":"NICE. Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease. Technology appraisal guidance [TA558] National Collaborating Centre for Cancer; 2019 Published date: 23 January 2019."},{"key":"10.1016\/j.ejogrb.2023.11.013_b0695","unstructured":"NICE. Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease . Technology appraisal guidance 558 2019."},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0700","first-page":"408","article-title":"Management of regional lymph nodes and their prognostic influence in vulvar cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0705","first-page":"402","article-title":"Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva","volume":"66","author":"Hoffman","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0710","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0715","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200601000-00050","article-title":"Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva","volume":"16","author":"Land","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0720","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.1960.tb09245.x","article-title":"Lymphatics of the vulva","volume":"67","author":"Parry-Jones","year":"1960","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0725","series-title":"Improving Outcomes in Gynaecological Cancer - the Research Evidence","author":"Melville","year":"1999"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b0730","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1136\/ijgc-2019-000798","article-title":"Sentinel lymph node consensus document of the British Gynaecological Cancer Society for endometrial, vulvar, and cervical cancers","volume":"29","author":"Fotopoulou","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0735","first-page":"CD010409","article-title":"Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer","volume":"6","author":"Lawrie","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0740","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/IGC.0000000000000860","article-title":"Groin recurrences in node negative vulvar cancer patients after sole sentinel lymph node dissection","volume":"27","author":"Klapdor","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.11.013_b0745","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/bjc.2014.205","article-title":"Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis","volume":"110","author":"Meads","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0750","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2013.04.023","article-title":"Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature","volume":"130","author":"Hassanzade","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0755","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2010.10.009","article-title":"Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results","volume":"120","author":"Crane","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0760","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/IGC.0000000000000419","article-title":"Sentinel lymph node biopsy in vulvar cancer using combined radioactive and fluorescence guidance","volume":"25","author":"Verbeek","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0765","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ygyno.2020.09.044","article-title":"Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial","volume":"159","author":"Deken","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0770","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-019-05415-2","article-title":"Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients","author":"Prader","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0775","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2016.01.013","article-title":"Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible","volume":"140","author":"van Doorn","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b0780","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/bjc.2013.631","article-title":"Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer","volume":"109","author":"Sutton","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0785","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2021.11.020","article-title":"The accuracy of intraoperative frozen section examination of sentinel lymph nodes in squamous cell cancer of the vulva","volume":"164","author":"Swift","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0790","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.bjc.6602343","article-title":"The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva","volume":"92","author":"Narayansingh","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0795","unstructured":"Groningen International Study on Sentinel Nodes in Vulvar Cancer-III (GROINSS-VIII) [Internet]. National Library of Medicine. National Center for Biotechnology Information. 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05076942."},{"issue":"8","key":"10.1016\/j.ejogrb.2023.11.013_b0800","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1245\/s10434-016-5114-6","article-title":"The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node","volume":"23","author":"Woelber","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0805","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2018.10.047","article-title":"Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors","volume":"152","author":"Nica","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.11.013_b0810","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/aogs.14157","article-title":"Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastases","volume":"100","author":"Ignatov","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0815","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12905-020-01165-5","article-title":"The potential risk of contralateral non-sentinel groin node metastasis in women with early primary vulvar cancer following unilateral sentinel node metastasis: a single center evaluation in University Hospital of D\u00fcsseldorf","volume":"21","author":"Winarno","year":"2021","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0820","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2022.07.017","article-title":"Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe","volume":"167","author":"Van der Kolk","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0825","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","article-title":"Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I","volume":"140","author":"Te Grootenhuis","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0830","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/IGC.0000000000000637","article-title":"Should groin recurrence still be considered as a palliative situation in vulvar cancer patients?: a brief report","volume":"26","author":"Frey","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0835","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.15341","article-title":"The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single-centre study","author":"Pouwer","year":"2018","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0840","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0002-9378(87)90132-3","article-title":"Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study","volume":"156","author":"Sedlis","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0845","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/IGC.0000000000001283","article-title":"The Impact of Saphenous Vein Sparing During Inguinal Lymphadenectomy on Postoperative Morbidity in Women With Vulval Cancer: An Updated Per-Groin Meta-analysis of Short-term Outcomes","volume":"28","author":"Tranoulis","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b0850","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/1097-0142(20001001)89:7<1520::AID-CNCR15>3.0.CO;2-N","article-title":"Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva","volume":"89","author":"Zhang","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0855","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejso.2013.02.012","article-title":"Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome?","volume":"39","author":"Baiocchi","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0860","first-page":"510","article-title":"Isolated groin recurrence in vulval squamous cell cancer (VSCC). The importance of node count","volume":"31","author":"Butler","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0865","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ygyno.2010.01.007","article-title":"Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?","volume":"117","author":"Courtney-Brooks","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0870","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IGC.0000000000000125","article-title":"Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer","volume":"24","author":"van Beekhuizen","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0875","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0090-8258(92)90247-G","article-title":"A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva","volume":"46","author":"Helm","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b0880","first-page":"490","article-title":"Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group","volume":"79","author":"Stehman","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0885","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0090-8258(92)90311-6","article-title":"Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO","volume":"45","author":"Origoni","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b0890","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/1097-0142(19941101)74:9<2491::AID-CNCR2820740916>3.0.CO;2-5","article-title":"Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva","volume":"74","author":"Paladini","year":"1994","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0895","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","article-title":"Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0900","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju426","article-title":"Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study","volume":"107","author":"Mahner","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0905","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1438.2006.00769.x","article-title":"Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dissection prior to radiation therapy","volume":"17","author":"Hyde","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0910","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2015.09.081","article-title":"Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma","volume":"139","author":"Nooij","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b0915","first-page":"733","article-title":"Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes","volume":"68","author":"Homesley","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0920","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose\u2013volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0925","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ygyno.2017.06.004","article-title":"Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors","volume":"146","author":"Hayes","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2022.02.006","article-title":"Complications and risk factors in vulvar cancer surgery - a population-based study","author":"Rahm","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0935","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/igc.0000000000001146","article-title":"Do groin drains reduce postoperative morbidity in women undergoing inguinofemoral lymphadenectomy for vulvar cancer?","volume":"28","author":"Pontre","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0940","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010933","article-title":"Wound drainage following groin dissection for malignant disease in adults","volume":"11","author":"Thomson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0945","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygyno.2017.06.031","article-title":"Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: a Dutch nationwide prospective study","volume":"146","author":"Pouwer","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0950","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2008.03.005","article-title":"A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study","volume":"110","author":"Carlson","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0955","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00404-019-05113-z","article-title":"Efficacy of a collagen-fibrin sealant patch (TachoSil\u00ae) as adjuvant treatment in the inguinofemoral lymphadenectomy for vulvar cancer: a double-blind randomized-controlled trial","volume":"299","author":"Baggio","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0960","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2004.07.022","article-title":"A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy","volume":"95","author":"Judson","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0965","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.suronc.2020.08.011","article-title":"Reduced morbidity by using LigaSure compared to conventional inguinofemoral lymphadenectomy in vulvar cancer patients: A randomized controlled trial","volume":"35","author":"Pouwer","year":"2020","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b0970","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/02841868409136031","article-title":"Treatment of recurrent squamous cell carcinoma of the vulva","volume":"23","author":"Simonsen","year":"1984","journal-title":"Acta Radiol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0975","article-title":"Negative pressure wound therapy for treating surgical wounds healing by secondary intention","volume":"6","author":"Dumville","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b0980","article-title":"Negative pressure wound therapy for surgical wounds healing by primary closure","volume":"5","author":"Norman","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b0985","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2016.09.023","article-title":"Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the national cancer data base","volume":"97","author":"Chapman","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b0990","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2013.05.036","article-title":"Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma","volume":"130","author":"Viswanathan","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b0995","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00432-015-2060-9","article-title":"Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins","volume":"142","author":"Ignatov","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b1000","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113375","article-title":"The prognostic role of the surgical margins in squamous vulvar cancer: a retrospective Australian Study","volume":"12","author":"Barlow","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ygyno.2020.06.503","article-title":"Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva","volume":"158","author":"Yang","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b1010","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3802\/jgo.2018.29.e61","article-title":"Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB\/II vulvar squamous cell carcinoma","volume":"29","author":"Micheletti","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2016.07.006","article-title":"Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?","volume":"65","author":"Nooij","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2022.01.029","article-title":"Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study","author":"Shapira-Frommer","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2021.11.004","article-title":"Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study","volume":"164","author":"Woelber","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.radonc.2018.03.023","article-title":"Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: a National Cancer Database study","volume":"129","author":"Rydzewski","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2015.03.056","article-title":"Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis","volume":"137","author":"Gill","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b1040","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","article-title":"Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome","volume":"64","author":"Beriwal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2021.01.003","article-title":"Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer","volume":"161","author":"Ashmore","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2020.09.019","article-title":"Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?","volume":"159","author":"Richman","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IGC.0000000000000938","article-title":"Primary versus preoperative radiation for locally advanced vulvar cancer","volume":"27","author":"Natesan","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.adro.2017.02.006","article-title":"Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes","volume":"2","author":"Rao","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2021.07.020","article-title":"Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study","volume":"163","author":"van Triest","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0090-8258(90)90367-T","article-title":"Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)","volume":"37","author":"Durrant","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b1090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IGC.0b013e31824b4058","article-title":"Weekly paclitaxel\/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer","volume":"22","author":"Han","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3802\/jgo.2014.25.1.22","article-title":"Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva","volume":"25","author":"Raspagliesi","year":"2014","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b1100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000487435","article-title":"Brief report on 3-weekly paclitaxel carboplatin efficacy in locally advanced or metastatic squamous vulvar cancer","volume":"83","author":"Amant","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2017.03.030","article-title":"Neoadjuvant and definitive chemotherapy or chemoradiation for stage III and IV vulvar cancer: A pooled Reanalysis","volume":"212","author":"Forner","year":"2017","journal-title":"Eur J Obstetrics Gynecol Reproductive Biol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1110","article-title":"Chemoradiation for advanced primary vulval cancer","volume":"4","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1115","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-00009577-200303001-00019","article-title":"Randomised study between neoadjuvant chemoradiotherapy and primary surgery for the treatment of advanced vulvar cancer","volume":"13","author":"Maneo","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b1120","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/annonc\/mdw242","article-title":"The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy","volume":"27","author":"Clancy","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2012.06.028","article-title":"Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva","volume":"127","author":"Horowitz","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b1130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdp043","article-title":"Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group)","volume":"20","author":"Witteveen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1135","doi-asserted-by":"crossref","first-page":"p. A590-A","DOI":"10.1136\/jitc-2022-SITC2022.0563","article-title":"563 A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer","author":"Lee","year":"2022","journal-title":"Regular and Young Investigator Award Abstracts"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1140","unstructured":"Pilot Study on Concurrent Cisplatin-based Chemotherapy Combined With Vaccination Therapy With the P16_37-63 Peptide in Patients With HPV- and p16INK4a-positive Cancer [Internet]. ClinicalTrials.gov. 2015. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02526316."},{"issue":"15_suppl","key":"10.1016\/j.ejogrb.2023.11.013_b1145","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.e14030","article-title":"Phase I\/IIa trial targeting p16INK4a by peptide vaccination in patients with human papillomavirus-associated cancer","volume":"33","author":"Reuschenbach","year":"2015","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejogrb.2023.11.013_b1150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1155","first-page":"1","article-title":"Pembrolizumab in recurrent squamous cell carcinoma of the vulva: case report and review of the literature","volume":"17","author":"Shields","year":"2018","journal-title":"Gynecol Obstet Invest"},{"issue":"28","key":"10.1016\/j.ejogrb.2023.11.013_b1160","doi-asserted-by":"crossref","first-page":"46204","DOI":"10.18632\/oncotarget.17581","article-title":"Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma","volume":"8","author":"Sznurkowski","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1165","series-title":"The NHS Long Term Plan","author":"NHS England","year":"2019"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1170","unstructured":"Macmillan: Personalised Care for People Living With Cancer. https:\/\/cdnmacmillanorguk\/dfsmedia\/1a6f23537f7f4519bb0cf14c45b2a629\/1539-source\/providing-personalised-care-for-people-living-with-cancer-tcm9-3556742019."},{"key":"10.1016\/j.ejogrb.2023.11.013_b1175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijnurstu.2017.08.010","article-title":"Effects of nurse-led home-based exercise & cognitive behavioral therapy on reducing cancer-related fatigue in patients with ovarian cancer during and after chemotherapy: A randomized controlled trial","volume":"78","author":"Zhang","year":"2018","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1470-2045(19)30715-6","article-title":"The role of self-management in cancer survivorship care","author":"Girgis","year":"2020","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2023.11.013_b1185","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ijgc-2019-000597","article-title":"Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery after Surgery (ERAS) program","volume":"29","author":"Miralpeix","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12905-022-01882-z","article-title":"Considerations for multimodal prehabilitation in women with gynaecological cancers: a scoping review using realist principles","volume":"22","author":"Saggu","year":"2022","journal-title":"BMC Womens Health"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjspcare-2016-001207","article-title":"Holistic needs assessment and care plans for women with gynaecological cancer: do they improve cancer-specific health-related quality of life? A randomised controlled trial using mixed methods","volume":"10","author":"Sandsund","year":"2020","journal-title":"BMJ Support Palliat Care"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1200","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ijgc-2018-000096","article-title":"Approach to sexual dysfunction in women with cancer","volume":"29","author":"Del Pup","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1205","first-page":"14","article-title":"Fertility preservation in women affected by gynaecological cancer: the importance of an integrated gynaecological and psychological approach","author":"La Rosa","year":"2020","journal-title":"ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2020.10.022","article-title":"Patient reported outcome measures among patients with vulvar cancer at various stages of treatment, recurrence, and survivorship","volume":"160","author":"Alimena","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jsm.12764","article-title":"Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study","volume":"12","author":"Aerts","year":"2015","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1220","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2018.04.558","article-title":"Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer","volume":"149","author":"Ferguson","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1225","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.ijrobp.2012.03.030","article-title":"Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy","volume":"84","author":"Damast","year":"2012","journal-title":"Int J Radiat Oncology*Biology*Physics"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1230","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007291.pub3","article-title":"Vaginal dilator therapy for women receiving pelvic radiotherapy","author":"Miles","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b1235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7748\/cnp.14.7.16.e1206","article-title":"Female sexual health after a cancer diagnosis","volume":"14","author":"Holmes","year":"2015","journal-title":"Cancer Nursing Practice"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b1240","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/13697137.2019.1606796","article-title":"Sexual function after cancer: paying the price of survivorship","volume":"22","author":"Bober","year":"2019","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.REO.0000000000000071","article-title":"Oncology Section EDGE Task Force on Cancer: A systematic review of patient-reported measures for sexual dysfunction","volume":"35","author":"Alappattu","year":"2017","journal-title":"Rehabil Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1250","first-page":"599","article-title":"Screening for sexual health concerns in survivors of gynecological cancer","volume":"28","author":"Roberts","year":"2020","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b1255","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.jsxm.2020.06.019","article-title":"Sexual morbidity assessment in gyne-oncology follow-up: development of the sexual well-being after cervical or endometrial cancer (SWELL-CE) patient-reported outcome measure","volume":"17","author":"White","year":"2020","journal-title":"J Sex Med"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.11.013_b1260","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/ijgc-2020-002001","article-title":"Psychosexual morbidity in women with ovarian cancer","volume":"30","author":"Logue","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1265","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","article-title":"Interventions to address sexual problems in people with cancer: american society of clinical oncology clinical practice guideline adaptation of Cancer Care Ontario Guideline","volume":"36","author":"Carter","year":"2017","journal-title":"J Clin Oncol"},{"issue":"46","key":"10.1016\/j.ejogrb.2023.11.013_b1270","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008722","article-title":"Incidence of lower limb lymphedema after vulvar cancer","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1275","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2019.10.009","article-title":"GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients","volume":"156","author":"Carlson","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b1280","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ijgc-2020-001682","article-title":"Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review","volume":"30","author":"Bona","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IGC.0000000000000311","article-title":"The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma","volume":"25","author":"Berger","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/ijgc-2019-001032","article-title":"Lower extremity lymphedema in patients with gynecologic malignancies","volume":"30","author":"Dessources","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejogrb.2018.06.024","article-title":"Bioelectrical impedance analysis; a new method to evaluate lymphoedema, fluid status, and tissue damage after gynaecological surgery - A systematic review","volume":"228","author":"Askl\u00f6f","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1300","doi-asserted-by":"crossref","first-page":"100902 -","DOI":"10.1016\/j.gore.2021.100902","article-title":"Severe lymphoedema in gynaecological cancers: Impact of pneumatic compression on quality of life","volume":"39","author":"Freyne","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b1305","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bjps.2019.03.013","article-title":"Lymphaticovenular anastomosis in the treatment of secondary lymphoedema of the legs after cancer treatment","volume":"72","author":"Phillips","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.11.013_b1310","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/ijgc-2021-002666","article-title":"Immediate lymphatic reconstruction: The time is right to prevent lymphedema following lymphadenectomy for vulvar cancer","volume":"31","author":"Ince","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1315","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/IGC.0b013e318287a8e8","article-title":"Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer","volume":"23","author":"Morotti","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1320","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/micr.30115","article-title":"Do surgical interventions for limb lymphoedema reduce cellulitis attack frequency?","volume":"37","author":"Sharkey","year":"2017","journal-title":"Microsurgery"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.11.013_b1325","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jgo.2020.02.012","article-title":"Do age and comorbidity impair recovery during two years after treatment for endometrial cancer?","volume":"11","author":"van Walree","year":"2020","journal-title":"J Geriatric Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b1330","first-page":"4881","article-title":"A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences","volume":"28","author":"Muls","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1335","first-page":"CD012529","article-title":"Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers","volume":"2018","author":"Lawrie","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ctro.2021.04.006","article-title":"The role of dietary supplements, including biotics, glutamine, polyunsaturated fatty acids and polyphenols, in reducing gastrointestinal side effects in patients undergoing pelvic radiotherapy: A systematic review and meta-analysis","volume":"29","author":"Bartsch","year":"2021","journal-title":"Clin Translat Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1345","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1107-x","article-title":"International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: A phase IV study","volume":"13","author":"Halkett","year":"2018","journal-title":"Radiat Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.11.013_b1350","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.clon.2016.06.004","article-title":"The three-item ALERT-B questionnaire provides a validated screening tool to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors","volume":"28","author":"Taylor","year":"2016","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1355","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/IGC.0000000000001211","article-title":"Assessing patient-reported quality of life outcomes in vulva cancer patients: a systematic literature review","volume":"28","author":"Froeding","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/flgastro-2014-100468","article-title":"Guidance: The practical management of the gastrointestinal symptoms of pelvic radiation disease","volume":"6","author":"Andreyev","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1365","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003455.pub2","article-title":"Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis","author":"van de Wetering","year":"2016","journal-title":"Cochrane Database of System Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2020.02.020","article-title":"Efficacy and safety of sacral nerve modulation for faecal incontinence after pelvic radiotherapy","volume":"146","author":"Mege","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1375","first-page":"10","article-title":"The effects of hyperbaric oxygen therapy on pelvic radiation induced gastrointestinal complications (Rectal bleeding, Diarrhea, and pain): A meta-analysis","author":"Yuan","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1380","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ygyno.2017.12.025","article-title":"Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study","volume":"148","author":"Soisson","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"S3","key":"10.1016\/j.ejogrb.2023.11.013_b1385","doi-asserted-by":"crossref","DOI":"10.1002\/nau.24380","article-title":"Can radiation-induced lower urinary tract disease be ameliorated in patients treated for pelvic organ cancer: ICI-RS 2019?","volume":"39","author":"Bosch","year":"2020","journal-title":"Neurourol Urodyn"},{"issue":"04","key":"10.1016\/j.ejogrb.2023.11.013_b1390","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1463423614000371","article-title":"Prevalence of female urinary incontinence and its impact on quality of life in a cluster population in the United Kingdom (UK): a community survey","volume":"16","author":"Cooper","year":"2015","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1395","unstructured":"National Institute for Health and Care Excellence. Urinary Incontinence and Pelvic Organ Prolapse in Women: management (ng123). In: Department for Health and Social Care, editor. London: Department for Health and Social Care; 2019. p. 1-82."},{"key":"10.1016\/j.ejogrb.2023.11.013_b1400","series-title":"Current management of radiation cystitis: a review and practical guide to clinical management","first-page":"585","author":"Pascoe","year":"2019"},{"issue":"2\u20133","key":"10.1016\/j.ejogrb.2023.11.013_b1405","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/21681805.2019.1611631","article-title":"Outcomes of reconstructive urinary tract surgery after pelvic radiotherapy","volume":"53","author":"Toia","year":"2019","journal-title":"Scandinavian J Urol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/iju.14130","article-title":"Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature","volume":"27","author":"Villeirs","year":"2020","journal-title":"Int J Urol"},{"issue":"20","key":"10.1016\/j.ejogrb.2023.11.013_b1415","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.294.20.2587","article-title":"Risk of pelvic fractures in older women following pelvic irradiation","volume":"294","author":"Baxter","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.11.013_b1420","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.32807","article-title":"Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: a prospective study of 239 women","volume":"126","author":"Salcedo","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1425","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijrobp.2020.05.013","article-title":"Radiation-induced insufficiency fractures after pelvic irradiation for gynecologic malignancies: a systematic review","volume":"108","author":"Razavian","year":"2020","journal-title":"Int J Radiat Oncology*Biology*Physics"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1430","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijrobp.2019.09.012","article-title":"Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: a meta-analysis and meta-regression of 3929 patients","volume":"106","author":"Sapienza","year":"2020","journal-title":"Int J Radiat Oncology*Biology*Physics"},{"issue":"Suppl 2","key":"10.1016\/j.ejogrb.2023.11.013_b1435","article-title":"Insufficiency fractures in postmenopausal gynaecological patients receiving pelvic radiotherapy treatment \u2013 can we prevent them by optimising bone health?","volume":"19","author":"Eastlake","year":"2019","journal-title":"Clin Med"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1440","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010604.pub2","article-title":"Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults","author":"van den Blink","year":"2018","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1445","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.77.OP6.2","article-title":"The evaluation of a musculoskeletal health package intervention to prevent bone toxicity in women with gynaecological malignancies undergoing pelvic radiotherapy. The RadBone randomised controlled feasibility study","author":"Grigoriadou","year":"2021","journal-title":"Endocr Abstr"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.11.013_b1450","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00330-019-06520-1","article-title":"Pelvic insufficiency fracture or bone metastasis after radiotherapy for cervical cancer? The added value of DWI for characterization","volume":"30","author":"Zhong","year":"2020","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1455","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s13669-019-0262-x","article-title":"Management of induced menopause in gynaecological cancers and their challenges","volume":"8","author":"Purohit","year":"2019","journal-title":"Curr Obstetr Gynecol Rep"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1465","doi-asserted-by":"crossref","unstructured":"Lete I, Fiol G, Nieto L, Santaballa A, Pl\u00e1 MJ, Mendoza N. The use of menopausal hormone therapy in women survivors of gynecological cancer: Safety report based on systematic reviews and meta-analysis. Eur J Gynaecol Oncol: IMR Press Limited; 2021. p. 1058-67.","DOI":"10.31083\/j.ejgo4205155"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1470","doi-asserted-by":"crossref","unstructured":"Hamoda H, Panay N, Pedder H, Arya R, Savvas M, on behalf of the Medical Advisory Council of the British Menopause S. The British Menopause Society & Women\u2019s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health. 2020;26(4):181\u2013209.","DOI":"10.1177\/2053369120957514"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.11.013_b1475","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2011.11.074","volume":"84","author":"Yi","year":"2012","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.11.013_b1480","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","article-title":"Radiation-induced neuropathy in cancer survivors","volume":"105","author":"Delanian","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.013_b1485","doi-asserted-by":"crossref","first-page":"21 -","DOI":"10.2147\/OTT.S71086","article-title":"Lumbosacral plexus delineation, dose distribution, and its correlation with radiation-induced lumbosacral plexopathy in cervical cancer patients","author":"Tunio","year":"2014","journal-title":"OncoTargets and Therapy"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.11.013_b1490","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12094-015-1458-9","article-title":"Quality of life in patients treated by adjuvant radiotherapy for endometrial and cervical cancers: correlation with dose\u2013volume parameters","volume":"18","author":"Pisani","year":"2016","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.11.013_b1495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.13104\/imri.2020.24.1.46","article-title":"MR imaging of radiation-induced lumbosacral plexopathy, as a rare complication of concomitant chemo-radiation for cervical cancer","volume":"24","author":"Hwang","year":"2020","journal-title":"Investigative Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.11.013_b1500","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ijgc-2019-001176","article-title":"British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)","volume":"30","author":"Newton","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:04:58Z","timestamp":1759557898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523008138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":300,"alternative-id":["S0301211523008138"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.11.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}